Canonical pathway analysis revealed significant inhibition of several cancer-related pathways, including ERK/MAPK, phosphoinositide 3-kinase (PI3K)/AKT, and CXCR4 signaling (Figure S1A). This evidence concerns the gene CXCR4 and cancer.